Data flow in clinical laboratories: could metadata and peridata bridge the gap to new AI-based applications?

Journal: Clinical chemistry and laboratory medicine
PMID:

Abstract

In the last decades, clinical laboratories have significantly advanced their technological capabilities, through the use of interconnected systems and advanced software. Laboratory Information Systems (LIS), introduced in the 1970s, have transformed into sophisticated information technology (IT) components that integrate with various digital tools, enhancing data retrieval and exchange. However, the current capabilities of LIS are not sufficient to rapidly save the extensive data, generated during the total testing process (TTP), beyond just test results. This opinion paper discusses qualitative types of TTP data, proposing how to divide laboratory-generated information into two categories, namely metadata and peridata. Being both metadata and peridata information derived from the testing process, it is proposed that the first is useful to describe the characteristics of data, while the second is for interpretation of test results. Together with standardizing preanalytical coding, the subdivision of laboratory-generated information into metadata or peridata might enhance ML studies, also by facilitating the adherence of laboratory-derived data to the Findability, Accessibility, Interoperability, and Reusability (FAIR) principles. Finally, integrating metadata and peridata into LIS can improve data usability, support clinical utility, and advance AI model development in healthcare, emphasizing the need for standardized data management practices.

Authors

  • Andrea Padoan
    Department of Laboratory Medicine, University-Hospital of Padova, via Giustiniani 2, Padova 35128, Italy.
  • Janne Cadamuro
    Department of Laboratory Medicine, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Glynis Frans
    Department of Laboratory Medicine, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Federico Cabitza
    Department of Informatics, Systems and Communication, University of Milano-Bicocca, Milano, Italy.
  • Alexander Tolios
    Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna, Vienna, Austria.
  • Sander De Bruyne
    Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • William van Doorn
    Central Diagnostic Laboratory, Department of Clinical Chemistry, Maastricht University Medical Center +, Maastricht, The Netherlands.
  • Johannes Elias
    MDI Limbach Berlin GmbH, Berlin, Germany.
  • Zeljko Debeljak
    Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
  • Salomon Martin Perez
    Unidad de Bioquímica Clínica, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Habib Ozdemir
    Department of Medical Biochemistry, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Türkiye.
  • Anna Carobene
    Laboratory Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.